Brief: Syros Announces Clinical Updates And 2022 Goals To Support Its Advancement To A Fully Integrated Biopharmaceutical Company

Syros Pharmaceuticals

10/01/2022 12:23

Jan 10 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS ANNOUNCES CLINICAL UPDATES AND 2022 GOALS TO SUPPORT ITS ADVANCEMENT
TO A
FULLY INTEGRATED BIOPHARMACEUTICAL COMPANY
    * SYROS PHARMACEUTICALS INC - EXPECTS TO REPORT DATA FROM THREE CLINICAL
TRIALS
ACROSS HEMATOLOGY AND SELECTIVE CDK INHIBITOR PROGRAMS IN 2022
    * SYROS PHARMACEUTICALS INC - NOW EXPECTS TO INITIATE PHASE 1 SINGLE AGENT
TRIAL
OF SY-5609 IN HEMATOLOGIC MALIGNANCIES IN 2H 2022
    * SYROS PHARMACEUTICALS INC - EXPECTS TO NOMINATE DEVELOPMENT CANDIDATE FROM
CDK12
PROGRAM IN 2H 2022

Source text for Eikon:  ID:nBw8sqJjWa 
Further company coverage:  SYRS.O